Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.
نویسندگان
چکیده
Cosignatories Jean-Jacques Amy, Rob Beerthuizen, Martin Birkhäuser, Teresa Bombas, Mitchell Creinin, Philip D Darney, Lisa Ferreira Vicente, Kristina Gemzell-Danielsson, Bruno Imthurn, Jeffrey T Jensen, Andrew M Kaunitz, Ali Kubba, Medard M Lech, Diana Mansour, Gabriele Merki, Thomas Rabe, Katarina Sedlecki, David Serfaty, Jacques Seydoux, Lee P Shulman, Regine Sitruk-Ware, Sven O Skouby, Anne Szarewski, James Trussell, Carolyn Westhoff
منابع مشابه
Comment on 'Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism': author's response.
I would like to thank Drs Terplan and Zuckerman for their comments on the recently published position statement, which myself and the other cosignatory authors take very seriously. If I may summarise Drs Terplan and Zuckerman‘s argument. It starts with the assumption that there is now clear evidence proving that levonorgestel (LNG)and norethisterone acetate (NETA)-containing combined oral contr...
متن کاملOral contraception: properties and side-effects of COCs and POPs
Combined oral contraceptives In the UK combined oral contraceptives (COCs), containing both oestrogen and progestogen, are the most popular method of contraception for women under age 30. The most common oestrogen used is ethinyl estradiol (EE), in doses between 20 and 35μg. Progestogens are classified according to their steroid structure and the timing of their introduction on to the market. T...
متن کاملOral contraceptives and venous thromboembolism: old questions revisited.
©FSRH J Fam Plann Reprod Health Care 2009: 35(4) Background Two studies recently published in the British Medical Journal, a retrospective cohort study using information from the Danish registries1 and the MEGA case-control study for which cases were identified via specialised anticoagulation clinics in The Netherlands,2 revisit the question of whether so-called ‘third generation’ combined oral...
متن کاملPulmonary embolism in a healthy woman using the oral contraceptives containing desogestrel
Venous thromboembolism is well known as one of the rare but serious adverse effects of combined oral contraceptives (COCs). The COCs with third and fourth generation progestogens were found to have higher risk of venous thrombosis than those with second generation progestogens. We present a case of pulmonary embolism in a 23-year-old nulligravid woman who was using COCs containing the third gen...
متن کاملThe Risk of Venous Thromboembolism Associated with Oral Contraceptive; the Search Is Still On
Dear editor: 1 few years after coming to the market, the first generation of oral contraceptive pills (OCPs) were linked to significant risk of venous thromboembolism (VTE). This increased risk was blamed on the presence of the estrogen-like compounds in these agents. Therefore, the efforts were initiated to decrease the VTE risk of OCPs by lowering the delivered estrogen content by adding prog...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
دوره 18 3 شماره
صفحات -
تاریخ انتشار 2013